Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Fibrin Imaging of DVT and PE
NCT04022915Phase 1Terminated
- Start
- May 2019
- Primary completion
- Jul 2022
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [64Cu]FBP8 in pulmonary embolism (PE), deep vein thrombosis (DVT) and venous thromboembolism (VTE). Primary endpoints: Location of the Thrombus Within the Lungs at 72 hours, Location of Clot Burden Measurements Within the Thigh at 72 hours and 1 more. Started May 2019; status: terminated.
02
Drugs
[64Cu]FBP8
03
Conditions
pulmonary embolism (PE)deep vein thrombosis (DVT)venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04022915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022915.